Skip to main content
ConductScienceScienceDex

James B. Doub

NIH Rank #17066
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 16088042Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Orthopedics

NIH Funding · FY2025

Linked Award Amount
$972K
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#17,066
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for James B. Doub. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing James B. Doub as a PI. Multi-PI records show the full award amount for context.

  • 1R21AI188355-01R21
    Preclinical Research to Determine Prosthetic Joint Infection Pathophysiology Needed to Direct Clinical Bacteriophage Therapy
    University of Pittsburgh
    $447.8K
    award amount
  • 5R01AR082167-04R01
    The Role of Teichoic Acid Glycosylation in Phage Activity and Selection in an Ongoing FDA Phase II/III Clinical Study of Bacteriophage Therapy in Chronic Periprosthetic Joint Infection
    University of Pittsburgh
    $359.7K
    award amount
  • 5R21AR084183-02R21
    The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocols
    Loyola University Chicago
    $164.5K
    award amount

Award organizations

Organizations that administered FY2025 awards listing James B. Doub as a PI.

University of Pittsburgh
PA
$807.5K
2 grants
Loyola University Chicago
IL
$164.5K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    R01 Grant Holder
  4. 2025
    $1M Cumulative Funding
  5. 2025
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as James B. Doub.

Kenneth L Urish
University of Pittsburgh
3
shared awards
Ashley Levack
Loyola University Chicago
2
shared awards

Explore further

Find collaborators for James B. Doub

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →